A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease
NCT07382349
Summary
The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.
Eligibility
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Outpatient clinic visit (in-person or telemedicine) at a participating clinic site * Demonstrated Screening Need due to High Risk Profile, which includes the following: Diagnostic Codes for MASLD or Hepatic Steatosis on Imaging PLUS at least one cardiometabolic risk factors; OR Chronically Elevated Liver Enzymes (\> 6 months); OR patient with impaired glycemic control (prediabetes/diabetes); OR 2 or more cardiometabolic risk factors present Exclusion Criteria: * Solid Organ Transplant Recipient * Existing Hepatology Relationship Evidenced by Prior Hepatology Visit Within 3 Years * Active Cancer Diagnoses * Diagnoses for Alcohol-Related Conditions * Pregnant Individuals * Receiving Palliative Care Services
Conditions2
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07382349